Heart risk study for kids with cancer pulled before start
NCT ID NCT04036045
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to find early markers of heart damage in children with cancer who receive a type of chemotherapy called anthracyclines. Researchers planned to use blood tests and heart scans to identify which children were at highest risk. However, the study was withdrawn before any participants were enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Olga Salazar
Hartford, Connecticut, 06106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict growth problems in childhood cancer survivors?
- Exercise as medicine: a new weapon in the fight against childhood cancer?
- Rebooting immunity: can vaccines shield childhood cancer survivors from preventable diseases?
- Can a peer coach help young people take control of their chronic illness?
- Decades after childhood cancer: what Survivors' health reveals
- Could light therapy ease nerve pain from childhood cancer treatment?